Lectures and Panels
Albert Einstein College of Medicine of Yeshiva University
http://www.einstein.yu.edu - Christopher Austin, M.D., director of the National Center for Advancing Translational Sciences (part of the NIH), presents "Catalyzing Translational Innovation" at the 2013 "Transforming Clinical and Translational Research" symposium hosted by the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore (ICTR).
http://www.einstein.yu.edu - Emil Kakkis, M.D., Ph.D., president of Everylife Foundation and Ultragenyx Pharmaceuticals, presents "Improvement of the Development Process for Rare Disease Therapeutics" at the 2013 "Transforming Clinical and Translational Research" symposium hosted by the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore (ICTR).
http://www.einstein.yu.edu - Christopher Chute, M.D., Dr.PH., professor of medical informatics at the Mayo Clinic's Center for Clinical and Translational Science, presents "Informatics as a Catalyst for the Evolution of Biology and Medicine" at the 2013 "Transforming Clinical and Translational Research" symposium hosted by the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore (ICTR).
http://www.einstein.yu.edu - Nirav Shah, M.D., M.P.H., New York State Health Commissioner, presents "Conducting Policy Reform & Research in the Era of Health Care Reform" at the 2013 "Transforming Clinical and Translational Research" symposium hosted by the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore (ICTR).
http://www.einstein.yu.edu - Susannah Fox, associate director of digital strategy at the Pew Internet & American Life Project, explains why she believes online networks among and between patients, caregivers and physicians are the way of the future. This talk was given at Einstein and is part of faculty development associated with a Josiah Macy Jr. Foundation grant that Einstein was awarded in 2012 to promote online professionalism among faculty and students. See accompanying release: http://www.einstein.yu.edu/news/releases/830/einstein-faculty-receive-grant-to-teach-social-media-professionalism-in-medicine/
http://www.einstein.yu.edu - Kevin Pho, M.D., founder of KevinMD.com, urges physicians to engage in the "PR battle online" against those who spread false health claims and pseudo-science using social media. This talk was given at Einstein and is part of faculty development associated with a Josiah Macy Jr. Foundation grant that Einstein was awarded in 2012 to promote online professionalism among faculty and students. See accompanying release: http://www.einstein.yu.edu/news/releases/830/einstein-faculty-receive-grant-to-teach-social-media-professionalism-in-medicine/
http://www.einstein.yu.edu - Farris Timimi, M.D., defines social media and discusses how patients are using #socialmedia and networking as an important tool to access #health information. Dr. Timimi is medical director of Mayo Clinic Center for Social Media. This talk was given at Albert Einstein College of Medicine as part of faculty development associated with the 2012 Education and Training to Professionalism Initiative by the Institute on Medicine as a Profession (IMAP) and the Josiah Macy Jr. Foundation. #hcsm. See accompanying release: http://www.einstein.yu.edu/news/releases/830/einstein-faculty-receive-grant-to-teach-social-media-professionalism-in-medicine/
http://www.einstein.yu.edu - Farris Timimi, M.D., defines social media and discusses how patients are using #socialmedia and networking as an important tool to access #health information. Dr. Timimi is medical director of Mayo Clinic Center for Social Media. This talk was given at Albert Einstein College of Medicine as part of faculty development associated with the 2012 Education and Training to Professionalism Initiative by the Institute on Medicine as a Profession (IMAP) and the Josiah Macy Jr. Foundation. #hcsm. See accompanying release: http://www.einstein.yu.edu/news/releases/830/einstein-faculty-receive-grant-to-teach-social-media-professionalism-in-medicine/
http://www.einstein.yu.edu - Farris Timimi, M.D., defines social media and discusses how patients are using #socialmedia and networking as an important tool to access #health information. Dr. Timimi is medical director of Mayo Clinic Center for Social Media. This talk was given at Albert Einstein College of Medicine as part of faculty development associated with the 2012 Education and Training to Professionalism Initiative by the Institute on Medicine as a Profession (IMAP) and the Josiah Macy Jr. Foundation. #hcsm. See accompanying release: http://www.einstein.yu.edu/news/releases/830/einstein-faculty-receive-grant-to-teach-social-media-professionalism-in-medicine/
Edward Burns, M.D., executive dean, presents opening remarks at "Licensing Einstein Technology: The Inside Story: Metastatic Melanoma & Pain Therapeutics." Presenters and panelists describe the path of a novel melanoma technology invented at Einstein — from its beginnings in the lab to its current stage in clinical trials sponsored by Pain Therapeutics, Inc. (September 24, 2009)
Ekaterina Dadachova, Ph.D., the Sylvia & Robert S. Olnick Faculty Scholar in Cancer Research, discusses the technology she invented with Arturo Casadevall, M.D., Ph.D., and Joshua Nosanchuk, M.D. The technology, radioimmunotherapy of metastatic melanoma with radiolabeled melanin-binding antibodies, was invented at Einstein and is now in clinical trials sponsored by Pain Therapeutics. (September 24, 2009)
Panelists discuss an Einstein innovation moving from "bench to bedside." Einstein-invented technology intended to treat metastatic melanoma is in clinical trials by Pain Therapeutics, Inc. Panelists include: Ekaterina Dadachova, Ph.D., the Sylvia & Robert S. Olnick Faculty Scholar in Cancer Research; John Harb, director of the office of biotechnology; and Remi Barbier,CEO of Pain Therapeutics, Inc. (September 24, 2009)
During a panel discussion on diabetes and stem cell therapy, Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, discusses type 1 and type 2 diabetes in detail and the potential role of stem cell therapy. The event was organized by the New York Stem Cell Foundation. (April 29, 2009).
Leading stem cell scientists and patient advocates talk about the latest developments in stem cell research and diabetes. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean participated in the panel discussion. The event was organized by the New York Stem Cell Foundation. (April 29, 2009)
Dominick Purpura, M.D., dean emeritus and distinguished professor of neuroscience at Einstein, discusses the sweeping new theory on autism he developed with Mark F. Mehler, M.D., chairman of neurology and director of the Institute for Brain Disorders and Neural Regeneration at Einstein. (April 1, 2009)